Evaluation of the effect of royal jelly on the side effects of methylprednisolone treatment
Phase 3
- Conditions
- Covid 19.Coronavirus infection, unspecifiedU07.1
- Registration Number
- IRCT20210616051596N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with positive PCR test who are treated with methylprednisolone.
Exclusion Criteria
Patients with diabetes,
immune deficiency
acute bacterial infectious disease
allergy to bee products
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver function factors (AST, ALT, ALKP, BILD, BILT). Timepoint: Daily. Method of measurement: Blood tet.;Renal function factors (Na, K, Cr and BUN). Timepoint: Daily. Method of measurement: Blood test.;Hematological factors (WBC, Hb, PLT). Timepoint: Daily. Method of measurement: Blood test.;FBS. Timepoint: Daily. Method of measurement: Blood test.;Dose and frequency of need for regular insulin (IR). Timepoint: Daily. Method of measurement: cheklist.;Dosage and frequency of corticosteroids. Timepoint: daily. Method of measurement: cheklist.;Clinical symptoms (chills, sore throat, abdominal pain, diarrhea, dyspnea, cough, shortness of breath). Timepoint: 7 day intervals. Method of measurement: Examination and questions.;Inflammatory factors (ferritin and LDH). Timepoint: 7 day intervals. Method of measurement: Blood test.;Disease severity. Timepoint: daily. Method of measurement: Need medical care, supportive oxygen, need mechanical ventilation.;Spo2. Timepoint: Daily. Method of measurement: Oximetry.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: Duration of hospitalization due to Covid-19. Method of measurement: File review.